Schutte T, Thijs A, Smulders Y M
Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Neth J Med. 2016 Dec;74(10):443-448.
D-dimer is routinely measured as part of the clinical diagnosis algorithms for venous thromboembolism (VTE). In these algorithms, low D- dimer cut-off values are used to generate a dichotomous test result that is sensitive, but very non-specific for VTE. A consequence of any test dichotomisation is loss of information that is hidden in the continuous spectrum of results. For D-dimer, the information conveyed by extremely elevated results may be particularly relevant. Our aim was to assess the differential diagnosis of extremely elevated D-dimer levels in a hospital setting.
Retrospective cohort study of patients > 18 years with an extremely elevated (> 5000 μg/l; > 10x cut-off to exclude VTE) D-dimer test result. Electronic medical records were reviewed for diagnoses.
A total of 759 extremely elevated D-dimer results were identified. After exclusion of 120 duplicate cases, 53 patients undergoing cardiopulmonary resuscitation, and 5 cases without diagnostic information, 581 cases were analysed. Their D-dimer ranged between 5030 and 239,000 μg/l, with a mean of 17,598 μg/l (SD 22,972 μg/l). Altogether, 89% of these patients had a diagnosis of VTE, sepsis and/or cancer. The prevalence was highest for pulmonary embolism (183 patients; 32%), followed by cancer (168 patients; 29%), sepsis (142 patients; 24%), trauma/surgery (142 patients; 24%), and deep vein thrombosis (73 patients; 13%).
Although D-dimer testing has a reputation for being very non-specific, an extremely elevated D-dimer is uniquely associated with severe disease, mainly including VTE, sepsis and/or cancer. These results suggest that, even if sharply elevated D-dimers are a seemingly solitary finding, clinical suspicion of severe underlying disease should be maintained.
D-二聚体作为静脉血栓栓塞症(VTE)临床诊断算法的一部分,通常会进行检测。在这些算法中,低D-二聚体临界值用于生成一个二分测试结果,该结果对VTE敏感,但特异性很差。任何测试二分法的结果都是会丢失隐藏在连续结果谱中的信息。对于D-二聚体而言,极高结果所传达的信息可能尤为重要。我们的目的是评估医院环境中D-二聚体水平极高时的鉴别诊断。
对年龄大于18岁且D-二聚体检测结果极高(>5000μg/l;>排除VTE临界值的10倍)的患者进行回顾性队列研究。查阅电子病历以确定诊断。
共识别出759个D-二聚体结果极高的病例。排除120例重复病例、53例接受心肺复苏的患者以及5例无诊断信息的病例后,对581例病例进行了分析。他们的D-二聚体范围在5030至239,000μg/l之间,平均为17,598μg/l(标准差22,972μg/l)。总体而言,这些患者中有89%被诊断为VTE、脓毒症和/或癌症。肺栓塞的患病率最高(183例患者;32%),其次是癌症(168例患者;29%)、脓毒症(142例患者;24%)、创伤/手术(142例患者;24%)和深静脉血栓形成(73例患者;13%)。
尽管D-二聚体检测以特异性差而闻名,但D-二聚体水平极高与严重疾病具有独特的相关性,主要包括VTE、脓毒症和/或癌症。这些结果表明,即使D-二聚体急剧升高看似是孤立的发现,也应保持对严重潜在疾病的临床怀疑。